| Literature DB >> 33834076 |
Hun-Ju Yu1,2, Ming-Tse Kuo1, Pei-Chang Wu1.
Abstract
PURPOSE: The purpose of this study is to investigate the clinical characteristics of presenile cataract and compare that to ten years ago in southern Taiwan.Entities:
Mesh:
Year: 2021 PMID: 33834076 PMCID: PMC8016560 DOI: 10.1155/2021/9385293
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Patient demographics.
| Factor |
| % |
|---|---|---|
| Male | 155 | 51.3% |
| Female | 147 | 48.7% |
| Axial length (AXL) | ||
| <26 mm | 160 | 53.0% |
| ≥26 mm (high myopia) | 142 | 47.0% |
| Diabetes mellitus (DM) | 81 | 26.8% |
| Without PRP | 27 | 33.3% |
| Post-PRP only | 28 | 34.6% |
| Post-PRP and TPPV | 26 | 32.1% |
| Hypertension | 65 | 21.5% |
| Other systemic disease | 56 | 18.5% |
| Ocular surgery | 79 | 26.2% |
| Post-TPPV | 60 | 76.0% |
| Post-LASIK | 14 | 17.7% |
| Post-SE | 3 | 3.8% |
| Others | 2 | 2.5% |
| Ocular trauma history | 18 | 6.0% |
| Steroid usage | 5 | 1.7% |
| Lens type | ||
| NS | 204 | 67.6% |
| PSCO | 76 | 25.2% |
| CO | 8 | 2.7% |
| Mature | 14 | 4.6% |
∗∗PRP: panretinal photocoagulation; TPPV: trans-pars plana vitrectomy; LASIK: laser-assisted in situ keratomileusis; SE: scleral buckle; NS: nuclear sclerosis; PSCO: posterior subcapsular opacity; CO: cortical opacity.
Figure 1Changes of incidence in lens types for presenile cataract in 10 years.
Figure 2Changes of incidence in DM and high myopia for presenile cataract in 10 years.
Age and axial length (AXL) difference between eyes with/without LASIK in myopia patients.
| Myopia patients post LASIK ( | Myopia patients without LASIK ( |
| |
|---|---|---|---|
| Age | 47.5 ± 1.5 | 47.1 ± 0.4 | 0.786 |
| AXL | 28.57 ± 0.67 | 27.43 ± 0.19 | 0.104 |
∗LASIK: laser-assisted in situ keratomileusis.
Age and axial length (AXL) difference between eyes with/without LASIK in high myopia patients.
| High myopia patients post-LASIK ( | High myopia patients without LASIK ( |
| |
|---|---|---|---|
| Age | 47.8 ± 3.2 | 46.7 ± 5.9 | 0.530 |
| AXL | 29.15 ± 1.94 | 28.45 ± 2.10 | 0.267 |
∗LASIK: laser-assisted in situ keratomileusis.